They analyzed serum levels of different growth factors in patients with metastatic colorectal cancer who were treated with an anti-EGFR antibody and also found a significant inverse correlation between serum levels of HGF and OS [42]. This evidence concerns the gene HGF and metastatic colorectal cancer.